{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-25-000069","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.378834+00:00","generated_at":"2026-05-18T05:43:56.073266+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Intensity Therapeutics annual meeting results: director elected, auditor ratified","bullets":["Mark A. Goldberg elected Class II director with 6,979,703 votes For, 222,974 Withheld.","EisnerAmper LLP ratified as independent auditor for FY2025; 10,929,292 For, 16,730 Against.","Approximately 59.73% of outstanding shares represented at the annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-25-000069","json":"https://secwatch.observer/filing/0001567264-25-000069.json","markdown":"https://secwatch.observer/filing/0001567264-25-000069.md","text":"https://secwatch.observer/filing/0001567264-25-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000069/0001567264-25-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000069/intensity-20250717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:43:56.073266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}